EA200200846A1 - Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором - Google Patents
Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцепторомInfo
- Publication number
- EA200200846A1 EA200200846A1 EA200200846A EA200200846A EA200200846A1 EA 200200846 A1 EA200200846 A1 EA 200200846A1 EA 200200846 A EA200200846 A EA 200200846A EA 200200846 A EA200200846 A EA 200200846A EA 200200846 A1 EA200200846 A1 EA 200200846A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alpha
- adrenoceptor
- prevention
- treatment
- diseases mediated
- Prior art date
Links
- 102000008841 Alpha 2B adrenoceptor Human genes 0.000 title abstract 4
- 108050000738 Alpha 2B adrenoceptor Proteins 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 230000001404 mediated effect Effects 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229940122859 Alpha 2b adrenoceptor antagonist Drugs 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Настоящее изобретение относится к применению селективного антагониста альфа-2В-адреноцептора для получения фармацевтического препарата, полезного для лечения или предупреждения у млекопитающих заболеваний, опосредуемых альфа-2В-адреноцептором, который является соединением, выбранным из группы, включающей соединения А, В, С, D и Е, раскрытые на схеме 1, или фармацевтически приемлемой солью указанного соединения. Настоящее изобретение также относится к способу лечения или предупреждения заболеваний, опосредуемых альфа-2В-адреноцептором у млекопитающих, который включает введение названному млекопитающему эффективного количества селективного антагониста альфа-2В-адреноцептора.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18202100P | 2000-02-11 | 2000-02-11 | |
| FI20000303A FI20000303A0 (fi) | 2000-02-14 | 2000-02-14 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
| PCT/FI2001/000105 WO2001058454A1 (en) | 2000-02-11 | 2001-02-07 | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200200846A1 true EA200200846A1 (ru) | 2002-12-26 |
Family
ID=26160944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200200846A EA200200846A1 (ru) | 2000-02-11 | 2001-02-07 | Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1253926A1 (ru) |
| JP (1) | JP2003522148A (ru) |
| KR (1) | KR20020080413A (ru) |
| AU (1) | AU780802B2 (ru) |
| BR (1) | BR0108221A (ru) |
| CA (1) | CA2399421A1 (ru) |
| CZ (1) | CZ20022884A3 (ru) |
| EA (1) | EA200200846A1 (ru) |
| EE (1) | EE200200435A (ru) |
| GE (1) | GEP20043356B (ru) |
| HR (1) | HRP20020746A2 (ru) |
| HU (1) | HUP0300032A3 (ru) |
| IL (1) | IL151017A0 (ru) |
| IS (1) | IS6476A (ru) |
| MX (1) | MXPA02007454A (ru) |
| MY (1) | MY133957A (ru) |
| NO (1) | NO20023773D0 (ru) |
| NZ (1) | NZ520500A (ru) |
| PL (1) | PL357872A1 (ru) |
| SK (1) | SK11472002A3 (ru) |
| WO (1) | WO2001058454A1 (ru) |
| YU (1) | YU59102A (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI116940B (fi) | 2001-07-20 | 2006-04-13 | Juvantia Pharma Ltd Oy | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
| EP1417182A1 (en) * | 2001-07-20 | 2004-05-12 | Oy Juvantia Pharma Ltd | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8416432D0 (en) * | 1984-06-28 | 1984-08-01 | Wyeth John & Brother Ltd | Benzoquinolizines |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US6150389A (en) * | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
-
2001
- 2001-02-07 HU HU0300032A patent/HUP0300032A3/hu unknown
- 2001-02-07 HR HRP20020746 patent/HRP20020746A2/xx not_active Application Discontinuation
- 2001-02-07 YU YU59102A patent/YU59102A/sh unknown
- 2001-02-07 MX MXPA02007454A patent/MXPA02007454A/es unknown
- 2001-02-07 PL PL01357872A patent/PL357872A1/xx not_active Application Discontinuation
- 2001-02-07 NZ NZ520500A patent/NZ520500A/en unknown
- 2001-02-07 EP EP01907585A patent/EP1253926A1/en not_active Withdrawn
- 2001-02-07 EE EEP200200435A patent/EE200200435A/xx unknown
- 2001-02-07 GE GE4893A patent/GEP20043356B/en unknown
- 2001-02-07 AU AU35510/01A patent/AU780802B2/en not_active Ceased
- 2001-02-07 JP JP2001557564A patent/JP2003522148A/ja active Pending
- 2001-02-07 EA EA200200846A patent/EA200200846A1/ru unknown
- 2001-02-07 CA CA002399421A patent/CA2399421A1/en not_active Abandoned
- 2001-02-07 CZ CZ20022884A patent/CZ20022884A3/cs unknown
- 2001-02-07 BR BR0108221-3A patent/BR0108221A/pt not_active IP Right Cessation
- 2001-02-07 WO PCT/FI2001/000105 patent/WO2001058454A1/en not_active Ceased
- 2001-02-07 IL IL15101701A patent/IL151017A0/xx unknown
- 2001-02-07 SK SK1147-2002A patent/SK11472002A3/sk unknown
- 2001-02-07 KR KR1020027010329A patent/KR20020080413A/ko not_active Ceased
- 2001-02-09 MY MYPI20010579A patent/MY133957A/en unknown
-
2002
- 2002-07-19 IS IS6476A patent/IS6476A/is unknown
- 2002-08-09 NO NO20023773A patent/NO20023773D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20043356B (en) | 2004-04-13 |
| AU3551001A (en) | 2001-08-20 |
| IS6476A (is) | 2002-07-19 |
| NZ520500A (en) | 2005-01-28 |
| NO20023773L (no) | 2002-08-09 |
| HUP0300032A3 (en) | 2006-01-30 |
| KR20020080413A (ko) | 2002-10-23 |
| BR0108221A (pt) | 2003-03-05 |
| EE200200435A (et) | 2003-12-15 |
| YU59102A (sh) | 2005-11-28 |
| SK11472002A3 (sk) | 2003-02-04 |
| AU780802B2 (en) | 2005-04-21 |
| MXPA02007454A (es) | 2004-08-23 |
| JP2003522148A (ja) | 2003-07-22 |
| HRP20020746A2 (en) | 2004-12-31 |
| MY133957A (en) | 2007-11-30 |
| HUP0300032A2 (en) | 2003-05-28 |
| IL151017A0 (en) | 2003-02-12 |
| CZ20022884A3 (cs) | 2003-02-12 |
| EP1253926A1 (en) | 2002-11-06 |
| NO20023773D0 (no) | 2002-08-09 |
| PL357872A1 (en) | 2004-07-26 |
| WO2001058454A1 (en) | 2001-08-16 |
| CA2399421A1 (en) | 2001-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200501496A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
| BG66085B1 (bg) | Фенилаланинови производни | |
| MXPA04005209A (es) | Antagonistas del receptor de adenosina a2a. | |
| WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
| EA200200132A1 (ru) | СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| EA200200846A1 (ru) | Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором | |
| ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
| RU2001118219A (ru) | Ингибитор ангиогенеза | |
| DE60004996D1 (de) | Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen | |
| BR0214293A (pt) | Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo | |
| DE60115237D1 (de) | Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien | |
| DE60108775D1 (de) | Methode zur behandlung von schlaganfall | |
| LV12459A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |